Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hepatitis C
|
347 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 0.969 | 196 | 2009 | 2019 | |||||
Hepatitis C, Chronic
|
80 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.900 | 1.000 | 41 | 2009 | 2020 | |||||
Pseudohyperkalemia Cardiff
|
60 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 1.000 | 20 | 2010 | 2017 | |||||
Liver carcinoma
|
942 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 0.947 | 19 | 2011 | 2019 | |||||
Liver Cirrhosis
|
189 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 1.000 | 14 | 2011 | 2018 | |||||
Cirrhosis
|
110 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 1.000 | 12 | 2011 | 2018 | |||||
Fibrosis, Liver
|
64 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 1.000 | 11 | 2010 | 2019 | |||||
Hepatitis B
|
519 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.100 | 0.818 | 11 | 2012 | 2015 | |||||
Steatohepatitis
|
75 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.080 | 0.875 | 8 | 2011 | 2017 | |||||
Human immunodeficiency virus (HIV) II infection category B1
|
56 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.060 | 1.000 | 6 | 2010 | 2018 | |||||
Hepatitis B, Chronic
|
84 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.050 | 1.000 | 5 | 2012 | 2015 | |||||
Liver diseases
|
100 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.050 | 1.000 | 5 | 2011 | 2017 | |||||
Chronic hepatitis C genotype 1
|
1 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.040 | 1.000 | 4 | 2011 | 2014 | |||||
Complete atrioventricular block
|
96 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.040 | 1.000 | 4 | 2013 | 2019 | |||||
Cytomegalovirus Infections
|
26 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.040 | 0.750 | 4 | 2014 | 2019 | |||||
Hepatitis
|
42 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.040 | 0.750 | 4 | 2011 | 2017 | |||||
Congenital hypoplasia of adrenal gland
|
13 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Diabetes
|
710 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
Diabetes Mellitus
|
824 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2013 | 2015 | |||||
Hepatitis D Infection
|
4 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2014 | 2017 | |||||
Hepatitis, Chronic
|
10 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2016 | 2018 | |||||
HIV Coinfection
|
3 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2013 | 2014 | |||||
X-linked Adrenal Hypoplasia
|
70 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.030 | 1.000 | 3 | 2011 | 2017 | |||||
Acute hepatitis C
|
2 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.020 | 1.000 | 2 | 2012 | 2015 | |||||
Anemia
|
94 | 0.547 | 0.520 | 19 | 39248147 | intron variant | C/T | snv | 0.39 | 0.020 | 1.000 | 2 | 2012 | 2020 |